These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7708526)

  • 21. Recombinant human erythropoietin and platinum-based chemotherapy in advanced ovarian cancer.
    Welch RS; James RD; Wilkinson PM; Belli F; Cowan RA
    Cancer J Sci Am; 1995; 1(4):261-6. PubMed ID: 9166486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy.
    Chang J; Couture F; Young S; McWatters KL; Lau CY
    J Clin Oncol; 2005 Apr; 23(12):2597-605. PubMed ID: 15452188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current management of fatigue and anemia in patients with cancer.
    Mock V; Olsen M
    Semin Oncol Nurs; 2003 Nov; 19(4 Suppl 2):36-41. PubMed ID: 14702919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy-associated hematopoietic toxicity.
    Kuhn JG
    Am J Health Syst Pharm; 2002 Aug; 59(15 Suppl 4):S4-7. PubMed ID: 12166034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epoetin alfa: patient management issues and development through recombinant DNA technology. Part 1: Focus on Epoetin alfa patient management and recombinant DNA technology.
    Latham D; Nichols E
    ANNA J; 1990 Aug; 17(4):311-4. PubMed ID: 2396857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of anemia in patients with tumors].
    Tesarová P; Kvasnicka J
    Cas Lek Cesk; 1995 Oct; 134(20):647-50. PubMed ID: 7489579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nursing care plan/patient teaching plan.
    ANNA J; 1989 Aug; 16(5):351. PubMed ID: 2774690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case study of the anemic patient: epoetin alfa--focus on CQI and patient management.
    Kammerer JK
    ANNA J; 1994 Aug; 21(5):282-5. PubMed ID: 8080342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case study of the anemic patient: epoetin alfa--focus on protocols.
    Kammerer JK
    ANNA J; 1994 Dec; 21(7):440-3. PubMed ID: 7872824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vesicant extravasation: myths and realities.
    Boyle DM; Engelking C
    Oncol Nurs Forum; 1995; 22(1):57-67. PubMed ID: 7708525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDA approves Epoetin Alfa use for AZT patients.
    Nephrol News Issues; 1991 Apr; 5(4):11. PubMed ID: 1961277
    [No Abstract]   [Full Text] [Related]  

  • 32. Erythropoietic agents in chemotherapy-induced anemia: a review of recent therapeutic progress, issues, and concerns.
    Boccia RV
    Curr Hematol Rep; 2004 Nov; 3(6):397-405. PubMed ID: 15496272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epoetin in cancer-related anaemia.
    Ludwig H
    Nephrol Dial Transplant; 1999; 14 Suppl 2():85-92. PubMed ID: 10334673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transfusion therapy: associated risks and alternative approaches.
    Picard VT; Sayers MH; Spinowitz BS; Richner RE
    ANNA J; 1990 Dec; 17(6):457-64. PubMed ID: 2256728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A flow sheet for follow-up after chemotherapy extravasation.
    Davis ME; DeSantis D; Klemm K
    Oncol Nurs Forum; 1995 Jul; 22(6):979-83. PubMed ID: 7567616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case management of the anemic patient. Epoetin alfa: focus on patient teaching.
    Sasak C; Giordano E
    ANNA J; 1990 Apr; 17(2):188-9. PubMed ID: 2327804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epoetin alfa (Eprex) and quality of life.
    Littlewood T
    Curr Med Res Opin; 2005; 21 Suppl 2():S1-2. PubMed ID: 15969857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrology nursing care plan and patient education plan for the patient receiving Epogen.
    Prowant BF; Gallagher NM; Binkley LS; Latham D; Nichols E
    ANNA J; 1991 Apr; 18(2):188-93. PubMed ID: 2025050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case study of the anemic patient: epoetin alfa--focus on vascular access.
    Thomas-Hawkins C
    ANNA J; 1995 Feb; 22(1):52-5. PubMed ID: 7598564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing patient care: minimizing the impact of chemotherapy-induced toxicities.
    ONS News; 2004; 19(9 Suppl):11-2. PubMed ID: 15478567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.